CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 2802 [2018-00824]
Download as PDF
<![CDATA[
2802
Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Regulation citation
Number of
respondents
Form name
Responses
per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Missing Report Form ..........
29
1
29
.08
3
.............................................
6,059,761
........................
6,059,761
........................
326,120
Total .............................
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–00825 Filed 1–18–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment
Health Resources and Service
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Centers for
Disease Control and Prevention (CDC)/
Health Resources and Services
Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment will
hold a public meeting.
DATES: February 22, 2018, 2:00 p.m. to
4:00 p.m. ET.
ADDRESSES: This teleconference meeting
will accommodate up to 100 attendees.
Parties may access the teleconference by
dialing 888–989–6421 and using
participant code 9874492. Participants
should call and connect 15-minutes
prior to the start of the meeting.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the CDC/HRSA Advisory
Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment should
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:05 Jan 18, 2018
Jkt 244001
contact CDR Holly Berilla, Senior Public
Health Analyst, Division of Policy and
Data (DPD), HIV/AIDS Bureau (HAB),
HRSA, in one of three ways: (1) Mail a
request to CDR Holly Berilla, Senior
Public Health Analyst, HRSA/HAB/
DPD, 5600 Fishers Lane, 09N156,
Rockville, Maryland 20857; (2) call 301–
443–9965; or (3) send an email to
hberilla@hrsa.gov.
SUPPLEMENTARY INFORMATION: The CDC/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment was established under
Section 222 of the Public Health Service
(PHS) Act, [42 U.S.C. Section 217a], as
amended.
The purpose of the CDC/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment is to advise the Secretary,
HHS; the Director, CDC; and the
Administrator, HRSA regarding
objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and
other STDs; prevention and treatment
efforts including surveillance of HIV
infection, AIDS, viral hepatitis, and
other STDs, and related behaviors;
epidemiologic, behavioral, health
services, and laboratory research on
HIV, viral hepatitis, and other STDs;
identification of policy issues related to
HIV/viral hepatitis/STD professional
eduction, patient healthcare delivery,
and prevention services; Agency
policies about prevention of HIV, viral
hepatitis and other STDs; treatment,
healthcare delivery, and research and
training; strategic issues influencing the
ability of CDC and HRSA to fulfill their
missions of providing prevention and
treatment services; programmatic efforts
to prevent and treat HIV, viral hepatitis,
and other STDs; and support to the
Agencies in their developoment of
responses to emerging health needs
related to HIV, viral hepatitis, and other
STDs. Information about the Committee
and the meeting agenda is available by
contacting CDR Holly Berilla at the
contact information above.
During the meeting, the CDC/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment will discuss workgroup
reports and updates, information
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
regarding the National Ryan White HIV/
AIDS Program Conference, and
Committee business-related items.
Agenda items are subject to change as
priorities dictate.
Due to the nature and time limitations
of the meeting, members of the public
will not have an opportunity to provide
oral comments, although written
comments may be submitted to CDR
Holly Berilla at the contact information
listed above at least 10 days prior to the
meeting. Individuals who need special
assistance should notify CDR Holly
Berilla at the contact information listed
above at least 10 days prior to the
meeting.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–00824 Filed 1–18–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Statement of Organization, Functions,
and Delegations of Authority
Office for Civil Rights, Office of
the Secretary, HHS.
SUMMARY: This notice establishes the
Conscience and Religious Freedom
Division in the Office for Civil Rights of
the Department of Health and Human
Services.
SUPPLEMENTARY INFORMATION: In
accordance with Executive Order 13798
Promoting Free Speech and Religious
Liberty (May 4, 2017), 82 FR 21675, and
the Attorney General’s Guidance on
Federal Law Protections for Religious
Liberty (October 6, 2017), Part A, Office
of the Secretary, Statement of
Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services (HHS), as last amended at 81
FR 95622 (December 28, 2016), is being
amended at Chapter AT, Office for Civil
Rights (OCR) to reflect the restructuring
of OCR as follows:
I. Under Chapter AT, Office for Civil
Rights (OCR), in the outline section
AGENCY:
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00824]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment
AGENCY: Health Resources and Service Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Centers for Disease Control and Prevention
(CDC)/Health Resources and Services Administration (HRSA) Advisory
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will
hold a public meeting.
DATES: February 22, 2018, 2:00 p.m. to 4:00 p.m. ET.
ADDRESSES: This teleconference meeting will accommodate up to 100
attendees. Parties may access the teleconference by dialing 888-989-
6421 and using participant code 9874492. Participants should call and
connect 15-minutes prior to the start of the meeting.
FOR FURTHER INFORMATION CONTACT: Anyone requesting information
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and
STD Prevention and Treatment should contact CDR Holly Berilla, Senior
Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS
Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR
Holly Berilla, Senior Public Health Analyst, HRSA/HAB/DPD, 5600 Fishers
Lane, 09N156, Rockville, Maryland 20857; (2) call 301-443-9965; or (3)
send an email to [email protected].
SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and Treatment was established under
Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section
217a], as amended.
The purpose of the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment is to advise the Secretary,
HHS; the Director, CDC; and the Administrator, HRSA regarding
objectives, strategies, policies, and priorities for HIV, viral
hepatitis, and other STDs; prevention and treatment efforts including
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs,
and related behaviors; epidemiologic, behavioral, health services, and
laboratory research on HIV, viral hepatitis, and other STDs;
identification of policy issues related to HIV/viral hepatitis/STD
professional eduction, patient healthcare delivery, and prevention
services; Agency policies about prevention of HIV, viral hepatitis and
other STDs; treatment, healthcare delivery, and research and training;
strategic issues influencing the ability of CDC and HRSA to fulfill
their missions of providing prevention and treatment services;
programmatic efforts to prevent and treat HIV, viral hepatitis, and
other STDs; and support to the Agencies in their developoment of
responses to emerging health needs related to HIV, viral hepatitis, and
other STDs. Information about the Committee and the meeting agenda is
available by contacting CDR Holly Berilla at the contact information
above.
During the meeting, the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment will discuss workgroup
reports and updates, information regarding the National Ryan White HIV/
AIDS Program Conference, and Committee business-related items. Agenda
items are subject to change as priorities dictate.
Due to the nature and time limitations of the meeting, members of
the public will not have an opportunity to provide oral comments,
although written comments may be submitted to CDR Holly Berilla at the
contact information listed above at least 10 days prior to the meeting.
Individuals who need special assistance should notify CDR Holly Berilla
at the contact information listed above at least 10 days prior to the
meeting.
Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-00824 Filed 1-18-18; 8:45 am]
BILLING CODE 4165-15-P
